ORASURE TECHNOLOGIES, INC (OSUR) Gross Margin
- Gross margin · 12 months: Value 42.58%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 42.58% | Gross profit / revenue. Period ending 2026-06-30. $47.86M ÷ $112.41M × 100 ≈ 42.58% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 47.86M USD | Gross Profit |
| Revenue | 112.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 64.55M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $47.86M | $112.41M | $64.55M | 42.58% |
| 2026-03-31 | $47.70M | $113.02M | $65.31M | 42.21% |
| 2025-12-31 | $48.20M | $115.02M | $66.82M | 41.90% |
| 2025-09-30 | $50.80M | $125.70M | $74.91M | 40.41% |
| 2025-06-30 | $56.09M | $138.53M | $82.44M | 40.49% |
| 2025-03-31 | $67.62M | $161.63M | $94.00M | 41.84% |
| 2024-12-31 | $79.39M | $185.83M | $106.44M | 42.72% |
| 2024-09-30 | $100.95M | $224.26M | $123.31M | 45.01% |
| 2024-06-30 | $128.22M | $273.54M | $145.31M | 46.88% |
| 2024-03-31 | $129.90M | $304.64M | $174.74M | 42.64% |
| 2023-12-31 | $171.65M | $405.47M | $233.82M | 42.33% |
| 2023-09-30 | $185.55M | $452.67M | $267.12M | 40.99% |
| 2023-06-30 | $187.73M | $479.94M | $292.22M | 39.11% |
| 2023-03-31 | $189.15M | $474.74M | $285.58M | 39.84% |
| 2022-12-31 | $147.64M | $387.48M | $239.84M | 38.10% |
| 2022-09-30 | $125.18M | $327.97M | $202.79M | 38.17% |
| 2022-06-30 | $100.46M | $265.42M | $164.97M | 37.85% |
| 2022-03-31 | $103.55M | $242.80M | $139.25M | 42.65% |
| 2021-12-31 | $117.60M | $233.67M | $116.07M | 50.33% |
| 2021-09-30 | $128.65M | $232.96M | $104.31M | 55.22% |
| 2021-06-30 | $137.47M | $227.06M | $89.58M | 60.55% |
| 2021-03-31 | $124.06M | $198.71M | $74.64M | 62.44% |
| 2020-12-31 | $101.87M | $171.72M | $69.85M | 59.32% |
| 2020-09-30 | $93.52M | $158.53M | $65.01M | 58.99% |
| 2020-06-30 | $84.88M | $146.51M | $61.63M | 57.93% |
| 2020-03-31 | $92.63M | $156.08M | $63.45M | 59.35% |
| 2019-12-31 | $94.58M | $154.60M | $60.02M | 61.18% |
| 2019-09-30 | $99.45M | $155.18M | $55.73M | 64.09% |
| 2019-06-30 | $106.35M | $165.08M | $58.73M | 64.42% |
| 2019-03-31 | $107.23M | $169.88M | $62.65M | 63.12% |
| 2018-12-31 | $113.61M | $181.74M | $68.13M | 62.51% |
| 2018-09-30 | $107.43M | $183.53M | (m) | 58.54% |
| 2018-06-30 | $103.53M | $179.95M | (m) | 57.53% |
| 2018-03-31 | $103.11M | $176.50M | (m) | 58.42% |
| 2017-12-31 | $98.96M | $167.06M | (m) | 59.23% |
| 2017-09-30 | $94.39M | $150.53M | (m) | 62.70% |
| 2017-06-30 | $92.42M | $140.47M | (m) | 65.79% |
| 2017-03-31 | $88.02M | $131.66M | (m) | 66.86% |
| 2016-12-31 | $88.03M | $128.20M | (m) | 68.66% |
| 2016-09-30 | $86.00M | $125.08M | (m) | 68.76% |
| 2016-06-30 | $84.00M | $122.69M | (m) | 68.46% |
| 2016-03-31 | $83.61M | $121.72M | (m) | 68.69% |
| 2015-12-31 | $80.29M | $119.72M | (m) | 67.07% |
| 2015-09-30 | $76.34M | $116.02M | (m) | 65.80% |
| 2015-06-30 | $74.38M | $114.00M | (m) | 65.24% |
| 2015-03-31 | $69.69M | $110.02M | (m) | 63.35% |
| 2014-12-31 | $66.62M | $106.46M | (m) | 62.58% |
| 2014-09-30 | $65.78M | $106.55M | (m) | 61.73% |
| 2014-06-30 | $62.00M | $103.38M | (m) | 59.98% |
| 2014-03-31 | $60.49M | $101.31M | (m) | 59.70% |
| 2013-12-31 | $58.59M | $98.94M | (m) | 59.22% |
| 2013-09-30 | $54.71M | $92.32M | (m) | 59.27% |
| 2013-06-30 | $53.67M | $89.76M | (m) | 59.79% |
| 2013-03-31 | $53.87M | $88.04M | (m) | 61.19% |
| 2012-12-31 | $55.57M | $87.82M | (m) | 63.28% |
| 2012-09-30 | $56.92M | $89.37M | (m) | 63.69% |
| 2012-06-30 | $56.62M | $88.96M | (m) | 63.64% |
| 2012-03-31 | $54.18M | $85.41M | (m) | 63.44% |
| 2011-12-31 | $51.72M | $81.88M | (m) | 63.16% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $47.36M | $75.01M | (m) | 63.13% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $47.13M | $77.03M | (m) | 61.19% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |